CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Syngene signs 10-year biologics manufacturing agreement with Zoetis
News
29 Sep 2023

Syngene signs 10-year biologics manufacturing agreement with Zoetis

Bangalore, 14 July 2022, Syngene International Limited announced the signing of a 10- year agreement with leading animal health company, Zoetis, to manufacture the drug substance for Librela® (bedinvetmab), a first in class monoclonal antibody used for treating osteoarthritis in dogs. Launched in Europe, the UK and Switzerland, the product won ‘Best new companion animal product’ by IHS Markit Connect in 2021 for its transformational impact on pain relief for canines suffering from this debilitating condition. 

Syngene signs 10-year biologics manufacturing agreement with Zoetis

Read PDF
Mentioned Companies
Syngene International Ltd.
View company profile
Related categories
Contract Manufacturing Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services) Contract Research Contract Research Organisations (CROs) (Services)